Liver transplantation--patient selection and timing

Area of Science:

• Hepatology
• Transplant Surgery
• Gastroenterology

Background:

• Liver transplantation is a vital treatment for numerous liver diseases, particularly end-stage decompensated liver disease.
• Decompensation signifies cirrhosis with complications like jaundice, ascites, hepatic encephalopathy, hepatorenal syndrome, or esophageal varices.
• Established guidelines from the British Society of Gastroenterology and American Association for the Study of Liver Disease aid in patient selection.

Purpose of the Study:

• To review the current landscape of liver transplantation for end-stage liver disease.
• To highlight the impact of evolving patient selection criteria.
• To emphasize the role of prognostic scoring systems in organ allocation.

Main Methods:

• Review of established clinical guidelines for liver transplant assessment.
• Analysis of the transition from waiting time to prognostic scoring for liver allocation.
• Discussion of the MELD/PELD scoring system's role in prioritizing patients.

Main Results:

• The Model for End-Stage Liver Disease (MELD) and Pediatric End-Stage Liver Disease (PELD) scoring systems offer a robust prognosis estimate.
• MELD/PELD have become central to liver allocation, prioritizing patients with the greatest clinical need.
• This shift aims to optimize the use of scarce donor organs.

Conclusions:

• Liver transplantation remains a critical intervention for end-stage liver disease.
• The MELD/PELD system represents a significant advancement in equitable organ allocation.
• Continuous evaluation of selection criteria is essential as new data emerges.